AI assistant
AROA BIOSURGERY LIMITED — Investor Presentation 2021
Jul 1, 2021
64426_rns_2021-07-01_7ff32381-dc4f-4ab5-837b-e5f371a49c5d.pdf
Investor Presentation
Open in viewerOpens in your device viewer
ASX ANNOUNCEMENT/MEDIA RELEASE 2 JULY 2021
==> picture [123 x 48] intentionally omitted <==
AROA BIOSURGERY INVESTOR DAY
Soft tissue regeneration company Aroa Biosurgery Limited (ASX:ARX, ‘Aroa’ or the ‘Company’) is pleased to announce it will hold an Investor Day for shareholders and interested parties at 10am-1pm NZT (8am-11am AEST) Monday 5 July 2021.
The event will be conducted both in-person at the Company’s Auckland headquarters as well as virtually. All attendees are required to register in advance of the event. The Company will take questions following each session.
Virtual attendance
Register for the Investor Day at: https://myevents.nz/aroa/investorsday/live.bsp
In-person attendance
Register by contacting Lorraine Shepherd at [email protected] Address: 64 Richard Pearse Drive, Auckland, New Zealand
Agenda (all times NZT)
Introduction 10.00 – 10.10am
Brian Ward (Chief Executive Officer)
AROA ECM™ Product Portfolio 10.10 – 10.40am
Dr Frazer Murray (Director of Global Marketing & Strategy)
US Sales 10.40 – 11.10am
Brad Adams (VP Commercial), Wes Snodgrass (Director National Accounts), Brian Ward (Chief Executive Officer)
Clinical Evidence 11.10 – 11.40am
Dr Brandon Bosque (Medical Science Liaison, Dr Barnaby May (Chief Scientific Officer)
Session Break 11.40 – 11.50am
Dead Space Management Platform 11.50am – 12.20pm
Shane Dowling (Medical Science Liaison), Isaac Mason (Director of Product Development)
Manufacturing Overview 12.20 – 12.50pm
Simone Von Fircks (Chief Operations Officer), Rod Stanley (Director Manufacturing)
FY2022 Outlook & Executive Q&A 12.50 – 1.00pm
Brian Ward (Chief Executive Officer), Brad Adams (VP Commercial), Dr Barnaby May (Chief Scientific Officer), Simone Von Fircks (Chief Operations Officer), James Agnew (Chief Financial Officer)
< ENDS >
Authorised on behalf of the Aroa Biosurgery Board of Directors by Brian Ward, CEO.
==> picture [277 x 11] intentionally omitted <==
AROA BIOSURGERY LIMITED 64 Richard Pearse Drive, Auckland, New Zealand AROABIO.COM
ASX ANNOUNCEMENT/MEDIA RELEASE 2 JULY 2021
==> picture [123 x 48] intentionally omitted <==
About Aroa Biosurgery:
Aroa Biosurgery is a soft-tissue regeneration company committed to ‘unlocking regenerative healing for everybody’. We develop, manufacture, sell and distribute medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Our products are developed from a proprietary AROA ECM™ technology platform, a novel extracellular matrix biomaterial derived from ovine (sheep) forestomach. Clinically proven with peer reviewed publications, AROA’s products have been used in more than four million procedures to date, with distribution into our key market of the United States via our direct sales force and our partner TELA Bio. Founded in 2008, AROA is headquartered in Auckland, New Zealand and is listed on the Australian Securities Exchange (ASX:ARX). www.aroabio.com/
Contacts
Investor Simon Hinsley Investor Relations [email protected] + 61 401 809 653
Media Australia New Zealand Matthew Wright Piet De Jong [email protected] [email protected] +61 451 896 420 +64 21 812 766
==> picture [277 x 11] intentionally omitted <==
AROA BIOSURGERY LIMITED 64 Richard Pearse Drive, Auckland, New Zealand AROABIO.COM